Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Scientists found a way to grow human hair cells in a lab that can create new hair when transplanted.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Wounding may stimulate hair growth, but more research is needed to confirm the safety and effectiveness of related treatments.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

SIRT7 protein is crucial for starting hair growth in mice.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Immune cells affect hair growth and could lead to new hair loss treatments.

Deslorelin implants successfully treated hair loss in two male Keeshonden dogs.

COVID-19 can cause hair loss, but specialists can help treat it.

Hair grows faster in the morning and is more vulnerable to damage from radiation due to the internal clock in hair follicle cells.

Multiple treatments work best for hair loss.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.